Ohio State University researchers have discovered a hereditary cancer syndrome that predisposes certain people to a melanoma of the eye, along with lung cancer, brain cancer and possibly other types of cancer.
Author: The Medical News
Dendrimers offers a new way to treat age-related macular degeneration, retinitis pigmentosa
Hitching a ride into the retina on nanoparticles called dendrimers offers a new way to treat age-related macular degeneration and retinitis pigmentosa. A study by investigators at Mayo Clinic, Wayne State University and Johns Hopkins Medicine shows tha…
Potential nanoparticle treatment for macular degeneration and retinitis pigmentosa
Hitching a ride into the retina on nanoparticles called dendrimers offers a new way to treat age-related macular degeneration and retinitis pigmentosa. A collaborative research study among investigators at Wayne State University, the Mayo Clinic and Jo…
IRIDEX announces data from MicroPulse laser therapy study on DME
IRIDEX Corporation today announced that data from a clinical study compiled over 10 years demonstrates the safety and efficacy of MicroPulse laser therapy for treating diabetic macular edema (DME) without the retina tissue damage associated with conven…
Scientists understand how nervous system becomes wired during early development
Thanks to a new study of the retina, scientists at UC Santa Barbara have developed a greater understanding of how the nervous system becomes wired during early development.
Albert Einstein College of Medicine and Montefiore establish Office of Clinical trials
Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University have established an Office of Clinical Trials (OCT) to bring new therapies more rapidly to patients through the facilitation of efficient, compliant and timely cond…
Post-baseline vision data from Lundbeck’s Sabril patient registry presented at AES meeting
Post-baseline vision data from Lundbeck’s Sabril patient registry is available for the first time today as a late-breaking poster presentation at the annual meeting of the American Epilepsy Society.
Japan approves Visian Toric Implantable Collamer Lens
STAAR Surgical Company, the leading developer, manufacturer and marketer of minimally invasive refractive lenses, today announced that its Visian Toric Implantable Collamer Lens has been approved by the Japanese Ministry of Health, Labor and Welfare.
Seizure drug slows spread of uveal melanoma
A drug commonly used to treat seizures appears to make eye tumors less likely to grow if they spread to other parts of the body, according to researchers at Washington University School of Medicine in St. Louis.
Regeneron’s Eylea for treating age related macular degeneration gets FDA nod
Regeneron Pharmaceuticals has received marketing approval for their eye drug – Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat “wet” age-related macular degeneration. The only other drug ap…
Retina Implant scientific advisory board approves multi-center phase of second human clinical trial
Retina Implant AG, the leading developer of subretinal implants for retinitis pigmentosa patients, today announced that its scientific advisory board is in full support of beginning the multi-center phase of the Company’s second human clinical trial. T…
FDA approves EYLEA for treatment of wet Age-related Macular Degeneration
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related…
New protein in the fruit fly eye may shed light on neurodegenerative diseases
Researchers at the University of Wisconsin-Madison and collaborators have discovered a powerful new protein in the eye of the fruit fly that may shed light on blinding diseases and other sensory problems in humans.
Malpractice lawsuits linked to surgeon depression and career burnout
According to the results of a new study published in the November 2011 Journal of the American College of Surgeons, malpractice lawsuits against U.S. surgeons occur often and can take a profound personal toll on the surgeon, resulting in emotional exha…
Researchers uncover mechanism that governs cell specialization
Researchers at then Albert Einstein College of Medicine of Yeshiva University have uncovered a mechanism that governs how cells become specialized during development.
First-ever phase 1 clinical trial of rectal HIV-prevention drug
A topically applied microbicide gel containing a potent anti-HIV drug has been found to significantly reduce infection when applied to rectal tissue that was subsequently exposed to HIV in the laboratory, according to a new study by the UCLA AIDS Insti…
Laser therapy to turn brown eyes blue
A laser treatment developed by Stroma Medical’s Dr. Gregg Homer takes only 20 seconds to perform but can turn brown eyes into blue ones permanently.
Long-duration space voyages can affect astronauts’ visual systems
A new study sponsored by NASA finds that space flights lasting six months or more can cause a spectrum of changes in astronauts’ visual systems.
Pupil can constrict without any input from brain
You’ve seen it on television: A doctor shines a bright light into an unconscious patient’s eye to check for brain death. If the pupil constricts, the brain is OK, because in mammals, the brain controls the pupil. Or does it? Now, researchers at Johns H…
Clinical-grade viral vector can cure choroideremia
Researchers at Ohio State University Medical Center and Nationwide Children’s Hospital have developed a viral vector designed to deliver a gene into the eyes of people born with an inherited, progressive form of blindness that affects mainly males.